Target-binding molecules for conditionally activated receptor signaling
TW202631670APending Publication Date: 2026-08-01CHUGAI PHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-09-05
- Publication Date
- 2026-08-01
Smart Images

Figure TWG2TA001070341_001 
Figure TWG2TA001070341_002 
Figure TWG2TA001070341_003
Abstract
The present invention relates to one or more target-binding molecules, each comprising a binding domain [S1] and a binding domain [S2] that are each capable of binding to a scaffold protein, a binding domain [R1] that is capable of binding to a first receptor protein, and a binding domain [R2] that is capable of binding to a second receptor protein. The target-binding molecule is capable of inducing receptor signaling of a receptor complex, conditioned upon binding to a scaffold protein.
Need to check novelty before this filing date? Find Prior Art